Press releases
- GSK Canada submits respiratory syncytial virus (RSV) vaccine candidate for regulatory review
- GSK welcomes agreement with the Government of Canada for the provision of pandemic and seasonal influenza vaccines
- Regulatory submission for GSK’s daprodustat accepted into Health Canada review
